Incompetent executive directors and leadership that breeds toxic people in FE&A - Avis employé Employé (anonyme) Merck

1,0
25 févr. 2024
Employé (anonyme)
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Ask me next time on pros

Inconvénients

Culture is not what it used to be. Used to have good leadership and directors. Low IQ leadership team, extreme gaslighting and divisive behavior by two of the executive directors, the woman is crazy, they like to blame you for their incompetence and lack of experience in this space. Like to talk badly behind your back.

Découvrez plus d’avis sur Merck

5,0
3 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

End of the year shutdown which includes paid time off

Inconvénients

The con for me at the time was that I had to relocate which wasn’t possible

4,0
2 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Inconvénients

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Voir les avis par: Utile|Évaluation|Date|Tout